Fonix Pharma

Advanced biologics & CHO solutions

Innovating Biologics Development

Advanced CHO cell line solutions for the future of biopharmaceutical manufacturing

First CHOice® Platform

Proprietary technology for high-performance cell line development

GMP-Ready Solutions

From research to commercial manufacturing with regulatory compliance

First CHOice®

Your vision is our mission — advanced cell lines & biologics

We design high-performance CHO host cell lines, matched media & feeds and scalable upstream/downstream processes — fast, reliable, and GMP-ready.

Trusted by innovators
ISO 9001:2015

Our Development Services

🧪

Cell Line Development (CLD)

Proprietary platform to derive high-producing CHO host cell lines and stable clones tailored to your molecule.

Learn More →
⚗️

Upstream Processing (USP)

Bioreactor process design and scale-up guidance that preserves product quality and increases titer.

Learn More →
🧾

Downstream Processing (DSP)

Integrated purification workflows with in-line analytics and robust CQA control.

Learn More →
📈

Custom analytical methods for potency, purity and stability to support regulatory filings.

Learn More →
50+
Customer Projects Completed
20+
Ready-to-use Cell Lines
4.5M L
Media & Feeds Produced

Key Products

🧴

First CHOice® Medium & Feeds

Proprietary formulations engineered to maximize productivity while preserving product quality. Optimized for CHO cell cultures with enhanced nutrient delivery and reduced metabolic waste.

Explore Formulations
🧬

Ready-to-use Cell Lines (R2U-Cells)

Adapted CHO host lines optimized for biosimilar manufacturing and rapid tech transfer. Pre-validated for high productivity and stability in various production systems.

View Cell Lines

News Update

ISO 9001 Certified

Achievement of ISO 9001:2015 — reinforcing our processes and quality management across operations.

About Fonix Pharma

Fonix Pharma GmbH was established in 2009 in a key biotech location. We specialize in the development of monoclonal cell lines for the production of advanced biologics and biosimilars.

Using our platform, we deliver robust processes — from cell line development to GMP-ready manufacturing support — with an emphasis on speed and cost-effectiveness.

Read More
Innovation in Biologics